Call for Abstract

11th World Drug Delivery Summit, will be organized around the theme “Frontiers Innovations in Drug Delivery Technology”

Drug Delivery 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Drug Delivery 2017

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Drug Delivery Conferences attains greater global significance as Drug Delivery plays a significant role in the future of pharmaceutical research Novel drug delivery system method by which a drug is delivered can have a significant effect on its efficacy. Conference includes topics like Polymers to enhance drug delivery technology by providing controlled release of therapeutic agents in constant doses over long periods, cyclic dosage, and tunable release of both hydrophilic and hydrophobic drugs. In vitro & in vivo dissolution testing is required to ensure that drug dissolves at a consistent rate from batch to batch of formulated drug product. Improvement of dissolution rate of poorly soluble drugs can be increased by dissolving them in liquid hydrophilic vehicles followed by soaking on highly porous materials. The major part is to deliver an innovative speech on the latest Targeted drug delivery is a method of delivering medication to a patient in a manner that increases the concentration of the medication in some parts of the body relative to others. Pharmacokinetic behavior in drug design and development for safety issues arising either as a result of animal toxicity testing or in the clinical program itself.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 1-1self-microemulsifying drug delivery systems (SMEDDSs)
  • Track 1-2Liposomes Drug Delivery Systems
  • Track 1-3Hydrogels drug delivery
  • Track 1-4Microspheres drug delivery
  • Track 1-5Solid Dispersion
  • Track 1-6Dynamic invitro-invivo studies
  • Track 1-7Advances in GRDDS
  • Track 1-8Osmotics Micro Pumps
  • Track 1-9Micronization Techniques
  • Track 1-10PH & Temperature sensitive
  • Track 1-11Controlled Drug Delivery Systems

To maximize knowledge of the current researcher on developing drug delivery via Novel techniques for formulation development, Drug Delivery conference themed quality topics on Liposomes, Dendrimer, Targeted Drug Delivery design, versatile polymer in Drug Delivery and Controlled Drug Delivery, Trans mucosal Drug Delivery, Optimization of pharmaceutical products, Sustained Drug Delivery Systems, are a uniquely architect session to play an important role in the fields of pharmaceutical formulation development and medicinal chemistry.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2016, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 2-1Sustained Drug Delivery Systems
  • Track 2-2Intracellular Drug Delivery Systems
  • Track 2-3Magnetically Induced Drug Delivery System
  • Track 2-4Transdermal Drug Delivery Systems
  • Track 2-5Dentrimer Drug Delivery Systems
  • Track 2-6Nanoparticulate Drug Delivery Systems
  • Track 2-7Ocular Drug Delivery Systems
  • Track 2-8Targeted Drug Delivery Systems
  • Track 2-9Transmucosal Drug Delivery Systems
  • Track 2-10Modified Drug Delivery Systems
  • Track 2-11Local Drug Delivery Systems
  • Track 2-12Blood Brain Barrier Delivery Systems

Aimed and specially designed session for young and senior researcher from academic on Novel routes in drug delivery where researcher interested for developing novel routes to minimize side effects for common routes by which a drug is brought into contact with the body session includes different routes of administration like Topical drug delivery via a large range of classes including but not limited to creams, foams, gels, lotions, and ointments. Pulmonary mode of drug delivery system route is gaining much importance in the present day research field as it enables to target the drug delivery directly to lung both for local and systemic treatment. Nasal drug delivery an alternative route restricted to intravenous administration this area has been widely investigated in recent years by academics. Topics like other novel routes wise Vaginal drug delivery covers self-insertion creams, foams, gels, irrigations and tablets, are known to reside in the vaginal cavity. Oral Drug Delivery routes to reaching different parts of the body via the bloodstream. Injectable formulations intended for administration by injection, infusion or implantation into the body.

The market is categorized on the basis of route of administration, end user, and region. The route of administration market is further segmented into oral, pulmonary, ocular, nasal, topical, injectable, implantable and transmucosal drug delivery technology. The topical drug delivery technology market segment is expected to witness the highest CAGR in the forecast period.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 3-1Pulmonary route of Antibiotics
  • Track 3-2Oral drug delivery routes
  • Track 3-3Intranasal drug delivery
  • Track 3-4Tropical drug delivery
  • Track 3-5Ocular drug delivery
  • Track 3-6Parentral routes
  • Track 3-7Vaginal route
  • Track 3-8Pulsitile Routes
  • Track 3-9Buccal routes
Pharmaceutical Nanotechnology session includes Drug Delivery using Nanotechnology, Nanoparticles permeability to BBB, Nanoparticles application, Nanoliposome-mediated delivery, MicroRNA therapeutics, recent breakthroughs in nanoparticle design to demonstrate their high potential as multifunctional drug delivery nanocarriers. Carriers for nanotechnology, Nanomedicine, magnetic nanoparticles. In this review Polymer Nanotechnology for Drug Delivery, Nano composite materials, to deliver highly efficient therapeutic compounds to patient a future aspect of Nanotechnology has a vast future ahead of it and we are constantly making breakthroughs in this industry every day.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

 

  • Track 4-1Nanoparticles
  • Track 4-2Design of Nanodrugs
  • Track 4-3Nanotechnology for Targeted siRNA Delivery
  • Track 4-4Future aspects of Pharmaceutical Nanotechnology
  • Track 4-5Silk fibroin nanoparticle
  • Track 4-6Coated Gold Nanoparticles
  • Track 4-7Nanotechnology for lung diseases
  • Track 4-8Nanomedicine
  • Track 4-9Nanotechnology from the bench to Scale up
  • Track 4-10Challenges and advances in nanotechnology
  • Track 4-11Cancer Targeting
  • Track 4-12Nanoliposome
  • Track 4-13Nanomedicines in Theranostics

Nucleic acids science and technologies experience tremendous progress and changes. The conference will feature prominent experts discussing latest advances in nucleic acids research and development: TNA for treating cancer and viral diseases in the near future for Drug Delivery includes Novel RNAi-Based Therapy, advances in siRNA delivery, oligonucleotide drug delivery, viral gene therapy and Artificial microRNAs, non-coding RNA (miRNA, piRNA, lncRNA, and lincRNA) this architect session to play an important role in the fields of cancer targeting and pharmaceutical nanotechnology.

The RNAi nucleic acid drug delivery market was worth $169.1 million globally in 2012 and by 2017 it is estimated the market will have matured. By 2017, the market for RNAi drug delivery could be around $1.1 billion globally, reflecting a compound annual growth rate (CAGR) of 45%.

  • Track 5-1Novel RNAi-Based Therapy
  • Track 5-2Nanoimmuology and RNA Nanotechnology
  • Track 5-3Strategies for siRNA delivery
  • Track 5-4Nanotechnologies Relevant to RNA Research
  • Track 5-5Oligonucleotide Drug Delivery
  • Track 5-6Formulation strategy for siRNA delivery
  • Track 5-7Importing from DNA Nanotechnology
  • Track 5-8MicroRNA Technology
  • Track 5-9Drug target miRNAs
  • Track 5-10Cancer-targeted siRNA delivery
  • Track 5-11Aptamer and Antisense
  • Track 5-12Viral gene therapy
  • Track 5-13Extracellular RNA for Biomarker Development
To maximize knowledge of the current researcher on developing drug delivery via smart polymers, Smart Drug Delivery conference themed quality topics on Biodegradable polymers, Dendrimer a versatile polymer in drug delivery are a uniquely architect session to play an important role in the fields of nanotechnology, pharmaceutical and medicinal chemistry.
 
Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza and Zoladex.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

 

  • Track 6-1Mucosal Drug Delivery System
  • Track 6-2Sonophoresis Drug Delivery System
  • Track 6-3Insitu Drug Delivery
  • Track 6-4Micelle Drug Delivery
  • Track 6-5Emulgel Drug Delivery
  • Track 6-6Microencapsulation Process
  • Track 6-7Delivery through Versatile polymers
  • Track 6-8Novel pharmaceutical ingredients
  • Track 6-9Activation Modulated Drug Delivery System
  • Track 6-10Protein and Peptide Drug Delivery
  • Track 6-11Microsponge Drug Delivery System
  • Track 6-12Lymphoid Drug Delivery System

Vaccine Drug Delivery are multidisciplinary scientific field that is currently undergoing rapid development. An important component of cancer vaccines is the development of novel vaccine delivery strategies, this session includes Laser technology for Vaccine Delivery, Challenges and opportunities For Vaccine Delivery These advances promise to accelerate the development and testing Jet injectors, micro needles, Needle free drug delivery technology, is an innovative technique to deliver drugs into a person's body without piercing their skin.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 7-1New Horizons in Vaccine Drug Delivery
  • Track 7-2Challenges and Opportunities For Vaccine Delivery
  • Track 7-3Needle-free delivery
  • Track 7-4Vaccines for cancer chemotherapy
  • Track 7-5Immunostimulatory systems
  • Track 7-6Jet injectors and microneedles
  • Track 7-7Self-Amplifying mRNA Vaccines
  • Track 8-1Drug Delivery Market Research
  • Track 8-2Generic Drug Manufacturer
  • Track 8-3Drug Delivery Device Company
  • Track 8-4Drug Delivery Pharmaceutical Companies
  • Track 8-5Contract Drug Delivery Companies
  • Track 8-6Commercial Manufacturing

The demand for biotherapeutics is continuously increasing, because many biopharmaceutical drugs are reaching later stage clinical trials. Most biotherapeutic drugs are recombinant monoclonal antibodies which are widely produced in mammalian cell lines because of the need for post-translational modifications that should be alike or at least similar to those obtained in humans. Thus, there is an increase in the market for cell line development. Moreover, advancements in upstream processing technologies have led to improvement in speed and efficiency of generating robust and highly productive cell line for large scale production of protein therapeutics and has propelled the market for cell line development.

Major drugs driving growth of the overall smart drug delivery market include Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza,  Zoladex, Beckton Dickinson & Company (U.S.), Beckman Coulter (U.S.), Boehringer Ingelheim Group (Germany), Catalent Inc. (U.S.), CMC Biologics A/S (Denmark), Lonza Group Ltd. (Switzerland), EMD Millipore (U.S.), Partec (Sysmex Corporation) (Japan), ProBioGen AG (Germany), Selexis SA (Germany), Sigma-Aldrich Co. LLC. (U.S.), Sony Biotechnology Inc. (U.S.), and Thermo Fisher Scientific Inc. (U.S.)

According to a New Market Research “Bio therapeutics as Novel Technique in Drug Delivery  - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2022”, the Bio therapeutics as Novel Technique in Drug Delivery  was valued at US$56.03 mn in 2015 and is anticipated to expand at a CAGR of 7.5% from 2015 to 2022 to reach US$99.84 mn by 2022.

 

  • Track 9-1Biotherapeutics formulations
  • Track 9-2Biotherapeutics Technique in Drug Delivery
  • Track 9-3Nonclinical toxicology testing strategies
  • Track 9-4Stability of Pharmaceutical products
  • Track 9-5Advances in computational modeling for bioavailability
  • Track 9-6Recent Developments in QBD
  • Track 9-7Services for the Pharmaceutical Industry
  • Track 9-8CRO – Contract Research Organisations
In this session we will focus on devices designed for drug delivery through the pulmonary and nasal routes. These routes are of interest for local delivery, as in asthma, but also for rapid delivery of drugs to the system circulation and direct delivery to the central nervous system. Devices that account for specific anatomical and physiological features of the intranasal and pulmonary routes will be featured.  Drug delivery devices are specialized tools for the delivery of a drug or therapeutic agent via a specific route of administration. Such devices are used as part of one or more medical treatments. Many in the industry have long felt overly burdened by what they consider to be an unnecessarily complex approval process. Critics claim it impedes innovation and delays the availability of better health care.
 
To change that perception, the FDA last year announced $40 million to a new Medical Device Innovation Consortium (MDIC) charged with simplifying the process of designing and testing new technologies. With input from industry, government, and other nonprofit organizations, public-private MDIC will prioritize the regulatory science needs of the medical device community and fund projects to streamline the process.
 
Current research on femtosecond laser microfabrication of fluidic devices is introduced to present their research to elaborate. The research on microfluidics provides highly sensitive microfluidic sensors for practical applications with significant advantages of portability, efficiency, sensitivity, versatility, and low cost.
  • Track 10-1Emerging Medical Devices
  • Track 10-2Controlled Release Devices for Drug Delivery
  • Track 10-3BioMEMS in Drug Delivery
  • Track 10-4Contact Lens
  • Track 10-5Emerging Medical Devices
  • Track 10-6Lancets
  • Track 10-7Contraceptions
  • Track 10-8Devices for Paediatric medicines
  • Track 10-9surgical sutures
The scope of this session on research in Recent Advances in Drug Delivery includes
 
Opportunities and challenges for Drug Delivery Market in the pharmaceuticals industry
Market revenues and forecasts for Drug Delivery Market in the global pharmaceutical industry from 2009 to 2025
The key geographies including the US, Europe, Japan and Emerging Hotspots such as India, Singapore and China
Technology trends in Drug Delivery Market that shape the industry
Qualitative analysis of the market drivers, barriers, future outlook and challenges for the Oral Drug Delivery Market Analysis of competitive landscape and the leading market players
  • Track 11-1Solid pharmaceutical dosage forms
  • Track 11-2Bioabsorbable intelligent
  • Track 11-3Coating Materials
  • Track 11-4Cancer biomarkers
  • Track 11-5Pro-drugs as novel drug delivery systems
  • Track 11-6Tumor targeting
  • Track 11-7Improve drug bioavailability
  • Track 11-8Cancer Drug Delivery
By focusing on challenges and opportunities in the drug-delivery technology market there is an increasing demand for effective and, ideally, non-invasive drug-delivery methods. This is especially the case for the biopharmaceutical sector, which has experienced an overwhelming growth due to advances in biotechnology. In 2009, over $12 billion were invested in biologics / biotechnology research and development (R&D), representing a 26% share in the total R&D expenditure. A recent report by the Pharmaceutical Research and Manufacturers of America (PhRMA) states that in 2015 there were 901 biological in development, targeting more than 100 diseases.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

 

  • Track 12-1Reducing Patient Compliance
  • Track 12-2Drug Delivery of poorly soluble drugs
  • Track 12-3Self-emulsifying drug delivery systems (SEDDS)
  • Track 12-4Overcoming challenges in pediatric drug delivery
  • Track 12-5Controlling the addictive nature of drugs
  • Track 12-6Polymeric enhancement

This session and track is intended to assist pharmaceutical scientists in the development of stable protein formulations during the early stages of the product development process, providing a comprehensive review of mechanisms and causes of protein instability in formulation development, coverage of accelerated stability testing methods and relevant analytical methods, and an overview of the drug substance manufacturing process. Preformulation and the development of traditional solutions and lyophilized formulations frequently used for intravenous delivery and non-traditional formulations are also addressed.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 13-1Controlled release system for Protein Delivery
  • Track 13-2Polymers for delivery of proteins
  • Track 13-3Nanotechnology for Protein Delivery
  • Track 13-4Nanochannels for Protein Delivery
  • Track 13-5Chitosan derivatives for Protein Delivery
  • Track 13-6Novel system for specific Protein Delivery
  • Track 13-7Release of Proteins from Polymers
  • Track 13-8Protein Delivery from Microspheres
  • Track 13-9Peptidal drug delivery
  • Track 13-10Peptide therapeutics
  • Track 13-11Cell-penetrating and cell-targeting

Equipment and Machinery for Drug Delivery session includes major area participants/ Vendors, Engineers in Equipments from Laboratory equipments, Analytical Equipments, Auto Injectors, Semi-Automatic R&D Equipment, Large volume Production Machineries and Drug Delivery Pilot Equipments.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

  • Track 14-1Laboratory equipments
  • Track 14-2Spheronization
  • Track 14-3Auto Injectors
  • Track 14-4Pen Injectors
  • Track 14-5Semi Automatic R&D Equipments
  • Track 14-6Efficiency and Repeatability
  • Track 14-7Wire Less Equipments
  • Track 14-8Compliance and International Standards
  • Track 14-9Analytical Equipments
  • Track 14-10Large volume Production Machinaries
  • Track 14-11Latest Innovations and Advancements
  • Track 14-12Twin-Screw Granulation
  • Track 14-13Drug Delivery Pilot Equipments
  • Track 15-1Consistent quality
  • Track 15-2Production performance and continuity of supply
  • Track 15-3Auditing and due diligence
  • Track 15-4Regulatory Issues, quality control, and business development
  • Track 15-5Bussiness opportunities in drug delivery
  • Track 15-6competitive costs of product

Biomedical engineering is the application of engineering to the biology and medicine and other health care diagnosis. Biomedical concerns with the problems related to diseases and their treatment that involve wide range of activities from medical designed instruments with developed technologies and methodologies. Biomedical material research is mainly focused on Biomedical companies and marketing analysis.

  • Track 16-1Advances in Biomedical Technology
  • Track 16-2Biomedical materials research
  • Track 16-3Biomedical companies and marketing analysis

The most fundamental goal in drug design is to predict whether a given molecule will bind to a target and if so how strongly. Molecular mechanics or molecular dynamics are most often used to predict the conformation of the small molecule and to model conformational changes in the biological target that may occur when the small molecule binds to it. The therapeutic response of a drug depends upon the interaction of drug molecules with cell on cell membrane related biological events at receptor sites in concentration dependent manner.

  • Track 17-1Advances in Drug Targeting components
  • Track 17-2Drug Targeting strategies
  • Track 17-3Drug Targeting strategies
  • Track 17-4Drug Targeting strategies
  • Track 17-5Drug Targeting strategies
  • Track 17-6Computer Aided Drug Design
  • Track 17-7Computer Aided Drug Design

A platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It's intended to create and facilitate the most optimized and viable meeting place for engaging people in global business discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities globally, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start and/or expand their business. Thus it is a perfect place to connect Entrepreneurs, Business Owners, Early Stage Companies and Established Corporates with National or International Investors, Corporate Investors and Potential Business Partners.

The drug delivery technology market is expected to reach USD 1,504.7 Billion by 2020 from USD 1,048.1 Billion in 2015, growing at a CAGR of 7.5% from 2015 to 2020. Factors such as rising prevalence of chronic diseases, growth of the biologics market, new product launches, and drug innovation and technological advancements are driving the growth of this market. On the other hand, patent expiry and patent cliff, increase in the injuries and side effects are hindering the growth of this market.

Nanomedicine is simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use of nanoparticles to improve the behaviour of drug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema. Nanomedicine has the potential to develop radical new therapies based on an unprecedented control over both intracellular processes and the extracellular environment at the nanometer scale. To create precise solutions for intricate medical challenges in the area of wound healing, tissue regeneration and mitochondrial disease physical scientists, medical doctors, and industrial partners, work closely in the Radboud Nanomedicine Alliance. The National Nanotechnology Initiative expects new commercial applications in the pharmaceutical industry that may include advanced drug delivery systems, new therapies, and in vivo imaging.

  • Track 19-1Nanomedicine and Drug Delivery
  • Track 19-2Nanomaterials for drug delivery
  • Track 19-3Synthesis of Nanoparticles for Drug Delivery